Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

4.2K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
4.2K
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

4.4K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
4.4K
Bioplastics01:27

Bioplastics

18
Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...
18
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

107
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
107
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

370
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
370
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

67
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
67

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of high intensity physical activity compared to routine counseling on renal function decline in patients with type 2 diabetes at high risk for kidney disease - the ACTIDIANE randomized controlled trial.

Diabetes & metabolism·2026
Same author

Benefits of thermal imaging in orbital inflammation disorders.

Journal of ophthalmic inflammation and infection·2026
Same author

Endocrine disruptors are contributing to type 2 diabetes mellitus.

Hormones (Athens, Greece)·2026
Same author

Contextual Transparency Supports Cognitive Control by Reducing Prefrontal Activation and Enhancing Cue Prioritization in Children.

Developmental science·2026
Same author

Statistical learning in childhood: Dimensions, developmental trajectory, and relation with cognitive control.

Child development·2026
Same author

Association of eating disorders and/or insulin omission with impaired glycaemic control in persons living with type 1 diabetes: cross-sectional analysis of the French SFDT1 study.

BMJ open·2026
Same journal

Metabolic profiling of human follicular fluid to unravel the pathways involved in polycystic ovary syndrome - a systematic review.

Reviews in endocrine & metabolic disorders·2026
Same journal

Exercise remodels the skeletal muscle immune microenvironment to ameliorate type 2 diabetes mellitus-induced muscle atrophy: From immunometabolism to organ crosstalk.

Reviews in endocrine & metabolic disorders·2026
Same journal

Family matters? A Systematic review of interventions addressing family-level mechanisms in the treatment of childhood and adolescent obesity.

Reviews in endocrine & metabolic disorders·2026
Same journal

What is measured and what is estimated in body composition? A clarification framework for terminology and interpretation.

Reviews in endocrine & metabolic disorders·2026
Same journal

Unveiling the role of aldosterone in metabolic dysfunction-associated steatotic liver disease.

Reviews in endocrine & metabolic disorders·2026
Same journal

Prenatal and postnatal maternal obesity and their associations with child nutrition and weight outcomes: A systematic review.

Reviews in endocrine & metabolic disorders·2026
See all related articles

Related Experiment Video

Updated: Mar 26, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

6.8K

Bisphenol A: Targeting metabolic tissues.

Nicolas Chevalier1,2,3, Patrick Fénichel4,5,6

  • 1Centre Hospitalier Universitaire de Nice, Hôpital de l'Archet 2, Service d'Endocrinologie, Diabétologie et Médecine de la Reproduction, 151 route de Saint-Antoine de Ginestière, CS 23079, 06202, Nice Cedex 3, France.

Reviews in Endocrine & Metabolic Disorders
|January 29, 2016
PubMed
Summary
This summary is machine-generated.

Environmental exposure to Bisphenol A (BPA), a common chemical, is linked to increased risks of obesity, metabolic syndrome, and type 2 diabetes. This review explores evidence connecting BPA to insulin resistance and pancreatic dysfunction.

Keywords:
Bisphenol ADiabetesEndocrine disruptorsEstrogensFetal programmingObesityType 2 diabetesXenoestrogen

More Related Videos

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production
06:46

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production

Published on: June 2, 2023

2.4K
Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
08:28

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays

Published on: April 26, 2018

6.6K

Related Experiment Videos

Last Updated: Mar 26, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

6.8K
Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production
06:46

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production

Published on: June 2, 2023

2.4K
Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
08:28

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays

Published on: April 26, 2018

6.6K

Area of Science:

  • Endocrinology
  • Environmental Health
  • Metabolic Disorders

Background:

  • Global rise in obesity, metabolic syndrome, and type 2 diabetes.
  • Genetic and lifestyle factors are known contributors.
  • Endocrine disrupting chemicals (EDCs) like Bisphenol A (BPA) are increasingly implicated.

Purpose of the Study:

  • To review epidemiological and experimental evidence linking BPA exposure to metabolic diseases.
  • To discuss potential mechanisms of BPA's action on metabolic health.
  • To highlight BPA's role as an environmental contributor to metabolic disorders.

Main Methods:

  • Summary of epidemiological studies on BPA exposure and metabolic outcomes.
  • Review of in vivo experimental data (animal studies).
  • Analysis of in vitro studies investigating cellular mechanisms.

Main Results:

  • Epidemiological and in vivo data suggest an association between BPA exposure and insulin resistance.
  • BPA exposure is linked to pancreatic beta cell dysfunction.
  • Evidence points to a connection between BPA and obesity development.

Conclusions:

  • BPA is a significant environmental factor contributing to metabolic diseases.
  • BPA may disrupt normal metabolic processes through various cellular pathways.
  • Further research is needed to fully understand BPA's impact on human metabolic health.